Advertisement
Advertisement
U.S. markets open in 4 hours 41 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Bio-Path Holdings, Inc. (BPTH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.4600+0.1000 (+2.98%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Gap Up

Gap Up

Previous Close3.3600
Open3.4399
Bid0.0000 x 1100
Ask4.8700 x 800
Day's Range3.2900 - 3.4601
52 Week Range2.6800 - 5.4000
Volume4,821
Avg. Volume21,564
Market Cap24.774M
Beta (5Y Monthly)1.45
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for BPTH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Bio-Path Holdings, Inc.
    Analyst Report: AMGEN Inc.Amgen, based in Thousand Oaks, California, is a leading global biotech company. Its key products include Repatha, Kyprolis, Prolia, Xgeva, Neulasta, and Enbrel. The shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    13 days agoArgus Research
View more
Advertisement
Advertisement